Your browser doesn't support javascript.
loading
Dense Array of Spikes on HIV-1 Virion Particles.
Stano, Armando; Leaman, Daniel P; Kim, Arthur S; Zhang, Lei; Autin, Ludovic; Ingale, Jidnyasa; Gift, Syna K; Truong, Jared; Wyatt, Richard T; Olson, Arthur J; Zwick, Michael B.
Afiliação
  • Stano A; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Leaman DP; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Kim AS; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Zhang L; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Autin L; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Ingale J; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Gift SK; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Truong J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Wyatt RT; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
  • Olson AJ; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, California, USA.
  • Zwick MB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
J Virol ; 91(14)2017 07 15.
Article em En | MEDLINE | ID: mdl-28446665
ABSTRACT
HIV-1 is rare among viruses for having a low number of envelope glycoprotein (Env) spikes per virion, i.e., ∼7 to 14. This exceptional feature has been associated with avoidance of humoral immunity, i.e., B cell activation and antibody neutralization. Virus-like particles (VLPs) with increased density of Env are being pursued for vaccine development; however, these typically require protein engineering that alters Env structure. Here, we used instead a strategy that targets the producer cell. We employed fluorescence-activated cell sorting (FACS) to sort for cells that are recognized by trimer cross-reactive broadly neutralizing antibody (bnAb) and not by nonneutralizing antibodies. Following multiple iterations of FACS, cells and progeny virions were shown to display higher levels of antigenically correct Env in a manner that correlated between cells and cognate virions (P = 0.027). High-Env VLPs, or hVLPs, were shown to be monodisperse and to display more than a 10-fold increase in spikes per particle by electron microscopy (average, 127 spikes; range, 90 to 214 spikes). Sequencing revealed a partial truncation in the C-terminal tail of Env that had emerged in the sort; however, iterative rounds of "cell factory" selection were required for the high-Env phenotype. hVLPs showed greater infectivity than standard pseudovirions but largely similar neutralization sensitivity. Importantly, hVLPs also showed superior activation of Env-specific B cells. Hence, high-Env HIV-1 virions, obtained through selection of producer cells, represent an adaptable platform for vaccine design and should aid in the study of native Env.IMPORTANCE The paucity of spikes on HIV is a unique feature that has been associated with evasion of the immune system, while increasing spike density has been a goal of vaccine design. Increasing the density of Env by modifying it in various ways has met with limited success. Here, we focused instead on the producer cell. Cells that stably express HIV spikes were screened on the basis of high binding by bnAbs and low binding by nonneutralizing antibodies. Levels of spikes on cells correlated well with those on progeny virions. Importantly, high-Env virus-like particles (hVLPs) were produced with a manifest array of well-defined spikes, and these were shown to be superior in activating desirable B cells. Our study describes HIV particles that are densely coated with functional spikes, which should facilitate the study of HIV spikes and their development as immunogens.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírion / HIV-1 / Virossomos / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírion / HIV-1 / Virossomos / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos